In recent years, chronic rejection has become a major factor mRNA in chronic renal allograft rejection in the rat.
cause of late renal graft loss after the first year [1] . AlBackground. Despite considerable progress in immunosupthough chronic renal allograft rejection has been tradipression, the incidence of chronic renal allograft rejection has tionally regarded as a repeated low-grade response to not decreased. Recent studies have revealed that angiotensinallogeneic tissue, recent evidence indicates that alloanticonverting enzyme (ACE) inhibition ameliorates graft arteriosclerosis, glomerulosclerosis, and tubular atrophy. Moreover, gen-independent factors may also contribute to its pathoit decreases systemic and glomerular capillary hydrostatic presgenesis [2] [3] [4] [5] [6] [7] . These factors include surgical trauma, issure in a rat kidney allograft model. We evaluated the effects chemia/reperfusion injury, cytomegalovirus infection, of the ACE inhibitor enalapril on cytokine and growth factor and donor age. expression in chronically rejecting rat kidney allografts. factor-I (IGF-I), platelet-derived growth factor (PDGF),
Regardless of etiology, these factors contribute to the
Conclusions. Treatment with enalapril attenuated the development of proteinuria, ameliorated morphological damage, and transforming growth factor-␤ 1 (TGF-␤ 1 )], which in decreased leukocyte infiltration, and prevented a rise in renal turn induce cell migration and proliferation of leukocytes mRNA levels of growth factors and cytokines in kidney grafts and smooth muscle cells (SMCs), and play a causative in a rat model of chronic renal allograft rejection.
role in extracellular matrix accumulation [11] . Moreover, the local (endothelial) and systemic renin-angiotensin system may be activated, thus causing posttransplant pertensive nephropathy) or after renal transplantation excised, and perfused with 4ЊC cold Ringer lactate. The kidneys were then positioned orthotopically in anesthe- [12] [13] [14] . The increased efficacy of ACE inhibitors in experimental models and clinical trials as compared with tized, weight-matched Lew recipients whose left renal vessels had been isolated, clamped, and the native kidney other antihypertensive drugs is probably caused by a reversal of angiotensin II-induced increase in resistance removed. Donor and recipient renal artery, vein, and ureter were anastomosed end to end using 10-0 prolene at the efferent arteriole [15] [16] [17] , and the influence on growth and migration promoting cytokines [18] . The sutures. The contralateral native kidney was removed on the 10th postoperative day. therapeutic effects of ACE inhibitors are independent of their systemic antihypertensive effects since they can Experimental protocol be observed in normotensives [19, 20] . Moreover, they reduce proteinuria more effectively in chronic renal disTo overcome infectious complications caused by operation and immunosuppression, rats received Cephtriaxease compared with ␤ blockers or calcium antagonists while having the same blood pressure-lowering effect [21] .
one (Rocephin, 20 mg/kg/day; Hoffmann-La Roche AG, Grenzach-Wyhlen, Germany) during the first 10 Angiotensin II acts as a growth factor for glomerular and tubular cells [22] and may directly induce collagen postoperative days. To prevent an initial episode of acute rejection, rats received 1.5 mg/kg/day cyclosporine A synthesis, an effect mediated by TGF-␤1 and PDGF-A [18] . Additionally, angiotensin II stimulates the adhesion (Novartis GmbH, Nü rnberg, Germany) for the first 10 postoperative days. Transplanted animals received of mononuclear cells to mesangial cells and the chemotaxis of macrophages and lymphocytes [23] . Therefore, either normal drinking water (controls, N ϭ 10) or 60 mg/L enalapril (MSD, Haar, Germany; enalapril group, in renal transplant recipients, ACE inhibition may not only effectively lower systemic blood pressure, but may N ϭ 10). As additional controls, a group of 12 Lew rats was sham operated and treated with cyclosporine A for also be antiproliferative and antimigrative as it reduces the release of cytokines and growth factors [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] .
10 days. Body weights and proteinuria were measured once Our present study was designed to determine the effects of the ACE inhibitor enalapril on the occurrence per month. After 20 weeks, rats were anesthetized with diethylether and bled, and the transplanted kidneys were and progression of chronic renal allograft rejection in the Fischer/Lewis model, as a standard transplant model removed. Samples were snap frozen in liquid nitrogen for immunohistological staining and polymerase chain for chronic rejection of the kidney in rats. This model is characterized by tubular atrophy, interstitial fibrosis, reaction (PCR) or fixed in formalin (4%) for light microscopy. intimal thickening of graft arteries, and glomerulosclerosis accompanied by severe proteinuria. Moreover, we
Functional measurements investigated the effects of ACE inhibition on the mRNA levels of growth factors and cytokines in rats with chronic Twenty-four-hour urine samples were collected every four weeks. Urinary protein and creatinine excretion, as kidney allograft rejection.
well as serum creatinine concentrations, was determined photometrically with commercially available test kits, METHODS and the creatinine clearance was calculated at the end Animals of the study. Experiments were performed with male inbred Fisher Histology (F344) and Lewis (Lew) rats with a body weight between 180 and 250 g. All animals were obtained from Charles For histology, kidney tissues were fixed in 4% buffered formalin, embedded in paraffin, and stained with hemaRiver (Sulzfeld, Germany) and housed in standard plastic cages and maintained in a temperature-and humiditytoxylin and eosin. The periodic acid-Schiff reaction was performed to evaluate the extent of glomerulosclerosis. controlled environment. The animals had access to standard chow food and tap water ad libitum. All experiIt was defined as a collapse of capillaries, adhesion of the obsolescent segment of Bowman's capsule, and the ments were approved by a governmental committee on animal welfare. entrapment of hyaline [26] . At least 200 glomeruli were counted in each kidney section, and the proportion of Renal transplantation sclerosed to total glomeruli was expressed as a percentage. Fisher (F344) rats served as donors, and Lew rats served as recipients. Under ketamine (100 mg/kg body Antibodies wt, intraperitoneally; Ketamin 10%; cp-pharma, Burgdorf, Germany), plus xylacine (10 mg/kg body wt, i.p.;
Monoclonal antibodies against macrophages (ED1), CD5ϩ T-lymphocytes (OX19), ICAM-1 (CD-54), and Rompun; Bayer, Leverkusen, Germany) anesthesia, the left kidney of each F344 donor rat was isolated, VCAM-1 (CD-106) were purchased from Serotec Ca-mon Labor-Service GmbH (Wiesbaden, Germany). The ribonuclease inhibitor (Promega, Madison, WI, USA), secondary rabbit antimouse antibody and the alkaline and 0.5 mL of 200 U/mL M-MLV reverse transcriptase phosphatase antialkaline phosphatase (APAAP) com-(GIBCO BRL) was added, and the first chain reaction plex were obtained from Dako A/S (Hamburg, Gerwas allowed to proceed (36ЊC, 1 h). The reaction was many).
halted by heating to 95ЊC for five minutes followed by cooling on ice.
Immunohistology
Representative portions of kidney grafts were snap Amplification of specific complementary DNA frozen in liquid nitrogen, cut with a cryostat (4 mm), Specific complementary DNA (cDNA) products corfixed in acetone at 4ЊC for five minutes, air dried, and responding to mRNA for TGF-␤ 1 [28] , PDGF-A chain stained with the respective antibodies. After incubation [29] , MCP-1 [30] , IGF-I [31] , IL-1 [32], angiotensinogen with the primary antibody, the sections were incubated
[33], and glyceraldehyde-3-phosphate dehydrogenase with rabbit antimouse IgG and with the APAAP com-(GAPDH) [34] were amplified using PCR. One milliliter plex. ICAM-1-and VCAM-1-like immunoreactivity from the RT reaction was taken for PCR, which was were quantitated on a grade 1 to 3 scale (1 ϭ mild, 2 ϭ performed in PCR buffer (750 mmol/L Tris hydrochlomoderate, 3 ϭ strong). Positive cell counts for macroride, pH 9.0, 200 mmol/L (NH 4 ) 2 SO 4 , 0.1% (wt/vol) phages (ED1) and T-lymphocytes (OX19) were exTween 20, 20 mmol/L magnesium dichloride (Dianova, pressed as a mean Ϯ SEM of cells per field of view Hamburg, Germany) using 0.2 mmol/L of each deoxy-(c/FV); Ͼ20 FV/section/specimen were evaluated at ϫ400.
nucleoside triphosphates, 1 mmol/L of both primers (Eurogentec, Kö ln, Germany), and 2.5 U thermus Aquaticus Total RNA isolation (Taq) DNA polymerase (Dianova, Hamburg, GerTotal RNA was extracted and used for reverse tranmany). A Perkin Elmer Thermal Cycler (Model 2400; scriptase-PCR (RT-PCR). Kidney tissue was stored in Perkin Elmer, Norwalk, CT, USA) was used for amplifi-500 mL of cold lysis solution containing 4 mol/L guanication with the following sequence profile: initial denadine isothiocyanate (Sigma, St. Louis, MO, USA), 25 turation at 94ЊC for three minutes, followed by 30 to 35 mmol/L sodium citrate (pH 7.0), 0.1 mol/L ␤-mercycles of three temperature PCRs (denaturing, 94ЊC for captoethanol, 0.5% sarcosyl and frozen in liquid nitrogen. 30 s; annealing, 55ЊC for 30 s; and extension, 72ЊC for Total RNA was extracted from the kidneys according to 30 s), ending with a final extension at 72ЊC for seven the modified guanidine-isothiocyanate preparation [27] .
minutes and cooling to 4ЊC. Briefly, frozen tissues were mixed with 4 mL GITC buffer (4 mol/L guanidine isothiocyanate; Sigma) and acid pheGel electrophoresis nolchloroform (pH 4, Roth), and homogenized. The
The amplified PCR product was identified by electrosamples were centrifuged at 1500 g for 10 minutes at phoresis of 10 mL sample aliquots on 1.5% agarose gel 20ЊC. The supernatant was added to an equal volume of stained with 0.5 mg/mL of ethidium bromide. The sample isopropanol followed by centrifugation. The RNA was products were visualized by ultraviolet transillumination, purified with the Rneasy, Total RNA Isolations Kit (Qiagen GmbH, Hilden, Germany), and stored at Ϫ80ЊC and the gel was photographed. Specific products were until further processing. The RNA concentration was identified by size in relationship to a known 1 kb oligonumeasured spectrophotometrically.
cleotide DNA ladder (GIBCO BRL) run with each gel. Cytokine cDNA was semiquantitated by densitometric Reverse transcription comparison with GAPDH (internal control) from the RNA was amplified by RT with an Oligo(dT) [12] [13] [14] [15] [16] [17] [18] same sample after the positive image was digitized by primer (GIBCO BRL, Karlsruhe, Germany). One millivideo for computerized densitometry. The results are gram of total RNA was added to 0.5 mg of primer. A given as the ratio of intensity of growth factors or cytoreaction mixture containing buffer solution [Tris hydrokines to GAPDH mRNA Ϯ SEM. chloride buffer in a concentration of 50 mmol/L (pH 8.3), potassium chloride in a concentration of 75 mmol/L, Statistical analysis magnesium dichloride in a concentration of 5 mmol/L, Results are expressed as mean Ϯ SEM. For statistical dithiothreitol in a concentration of 5 mmol/L; GIBCO analysis, a paired Student's t-test was used. Nonmetric BRL], adenosine triphosphate, thymidine triphosphate, parameters such as the intensity of staining for adhesion guanosine triphosphate, and cytosine triphosphate each molecules were evaluated with Fischer's exact test for in a concentration of 0.2 mmol/L (deoxynucleoside triordinal data [35] . A P value of Ͻ0.05 was considered to phosphates from Boehringer Mannheim GmbH, Mannheim, Germany), 0.5 mL of 40 U/mL of recombinant be statistically significant. 
RESULTS
with the enalapril-treated group. In the control group, three animals had no tubular atrophy. Four animals had Functional measurements grade 1, and three animals showed a grade 2 tubular While controls developed significant and progressive atrophy. In the enalapril-treated group, five animals had urinary protein excretion after 16 weeks, enalaprilno tubular atrophy. Five had grade 1, and no animal treated recipients had minimal urinary protein excretion displayed a grade 2 or 3 tubular atrophy (Table 2) . These during the entire 20-week follow-up period (at 20 weeks results did not differ statistically between the two groups. 48 Ϯ 3.6 vs. 23 Ϯ 0.73 mg/24 h, P Ͻ 0.05; Table 1 ).
Intimal proliferation. There was a trend toward more Creatinine clearance did not differ significantly between severe intimal proliferation in controls as compared with the two groups at the end of the 20-week follow-up enalapril-treated animals. In the control group, two aniperiod (controls 1.5 Ϯ 0.1 mL/min vs. treated 1.6 Ϯ 0.1 mals did not demonstrate intimal proliferation. Six animL/min). Sham-operated animals did not develop any mals had grade 1, and two grade 2 intimal proliferation. significant proteinuria.
In enalapril-treated animals, grade 1 intimal proliferaMean arterial blood pressure tion was evident in four animals, while all others had no intimal proliferation. These results were not statistically The mean arterial blood pressure was not significantly different between control and enalapril-treated animals different between the two groups (Table 2) . (94 Ϯ 10.2 vs. 90 Ϯ 8.9 mm Hg).
Immunohistology. At week 20, mononuclear cell infiltration was apparent in both groups. Cellular infiltraBody weight tion was most intense in interstitial areas, particularly Body weight tended to be lower in controls as comaround vessels and glomeruli. Whereas some lymphopared with enalapril-treated animals (419 Ϯ 15 vs. 429 Ϯ cytes surrounded Bowman's capsule, almost none were 11 g).
observed within the glomeruli. Only macrophages could be detected within the glomerular tuft. The numHistology ber of macrophages and lymphocytes was significantly All transplants developed changes of chronic rejection reduced in the treated group as compared with controls such as glomerulosclerosis, interstitial fibrosis, tubular (Table 3) . atrophy, and intimal proliferations of graft arteries durThe presence of leukocytes was associated with a ing the observation period [11, 36, 37] . However, the strong immunoreactive signal of adhesion molecules degree differed between the groups; treatment with ena-(ICAM-1, VCAM-1). The ICAM-1-like immunoreaclapril significantly ameliorated signs of chronic rejection, tive signal was predominantly higher on endothelial cells particularly glomerulosclerosis (Table 2 and Fig. 1) .
of small vessels, mesangial cells, and tubular epithelial Glomerulosclerosis. Glomerulosclerosis was significells, whereas VCAM-1-like immunoreactivity was most cantly higher in controls (26 Ϯ 1.7%) than in enalaprilpronounced on tubular epithelial cells. Treatment with treated animals (19 Ϯ 1.8%, P Ͻ 0.05).
enalapril significantly reduced the immunoreactive signal Interstitial fibrosis. Animals in the control group had of both adhesion molecules (P Ͻ 0.01; Table 3 ). TGFsignificantly more interstitial fibrosis as compared with ␤-like immunoreactivity was mainly found on interstitial the enalapril-treated animals (P Ͻ 0.05). In the control cells within the grafts. The number of cells with TGFgroup, one animal had no signs of interstitial fibrosis.
␤-like immunoreactivity was low in treated and control Three had grade 1 fibrosis. Six had grade 2, and no animals with a tendency toward a higher number in anianimals developed grade 3 fibrosis. In the enalaprilmals with moderate fibrosis and was confined to interstitreated group, five animals had no signs of interstitial tial cells within the graft. fibrosis. Five animals had grade 1 fibrosis, and no animal Sham-operated animals developed no signs of chronic displayed grades 2 or 3 fibrosis (Table 2) . rejection, neither histologically nor immunohistologiTubular atrophy. There was a trend toward more severe tubular atrophy in the control group as compared cally. Growth factor mRNA levels model render the possibility that the observed histologic changes are due to cyclosporine A nephrotoxicity highly Growth factor mRNA levels paralleled the developunlikely. Thus, it came as no surprise that sham-operated ment and progression of interstitial fibrosis and glomeruanimals did not develop any signs of chronic rejection. losclerosis [3, 37, 38] 20 weeks after transplantation.
This confirms the results of our previously published PDGF-A chain mRNA levels were fourfold higher in experiments [43, 44] . controls than in enalapril-treated animals. TGF-␤ 1
In our study, controls developed massive 24-hour promRNA levels in the enalapril-treated group were 1.6-tein excretion 20 weeks after transplantation. The adminfold lower than in controls. Additionally, treatment with istration of enalapril resulted in a significantly reduced enalapril significantly reduced the mRNA levels of 24-hour protein excretion. The mechanisms involved are PDGF-B chain and IGF-I (1.5-fold; Fig. 2 ).
hypothesized to be an intraglomerular and/or a direct The mRNA levels of MCP-1, a potent chemotactic ACE inhibitory effect on glomerular cells. In rats, intrafactor specific for monocytes/macrophages and a contribglomerular hypertension is thought to induce protein utor of chronic inflammatory responses [39] , was also loss by the formation of large, nonselective pores in the significantly lower in the enalapril-treated group (Fig.  glomerular wall, prior to the development of glomerulo-2). MCP-1 mRNA levels paralleled the number of monosclerosis [45] . Micropuncture studies suggest that lownuclear cells infiltrating the graft.
ering the glomerular capillary hydraulic pressure by The expression of the monocyte/macrophage product ACE inhibition reduces proteinuria by a reduction of IL-1␤ mRNA, also implicated in the development of the number of large pores in the glomerular wall [14, sclerosis and fibrosis, was significantly reduced (2.5-fold) 46]. Therefore, this effect might protect the kidney from in the enalapril-treated group as compared with controls further damage and thus prevent the progression of renal (Fig. 2) . As with MCP-1, the decreased level of IL-1␤ disease. In addition, Amann et al demonstrated in a subtotal nephrectomy model in rats that ACE inhibitors, mRNA correlated to a decreased number of macrobut not other antihypertensive drugs, prevented podophages. Angiotensinogen mRNA levels were significyte injury closely associated with the reduction of procantly higher in enalapril-treated animals as compared teinuria [47] . Lewis et al demonstrated a more prowith controls (P Ͻ 0.05; Fig. 2) . nounced reduction of proteinuria in patients with chronic renal disease with ACE inhibitors as compared with patients treated with calcium antagonists or ␤ blockers, DISCUSSION although the blood pressure-lowering effect was similar The beneficial effects of ACE inhibition on the proin all groups [21] . gression of renal disease and chronic renal allograft rejecIn controls of the present experiment, progressive glotion have been demonstrated in different animal models merulosclerosis and severe glomerular as well as intersti- [25, [40] [41] [42] . However, the precise mechanisms of action tial infiltration of macrophages and lymphocytes were remained unknown. Our present study demonstrated deobserved, whereas these changes were markedly reduced creased levels of growth factor mRNA in transplanted in the enalapril group. These findings could be related to rat kidneys following ACE inhibition, associated with a modification of proliferative and immunomodulatory attenuation of chronic renal allograft rejection. The very signals mediated by angiotensin II. Angiotensin II has been reported to have immunoregulating effects, such short time and low dose of cyclosporine A used in our as leukocyte adhesion and chemotaxis [48, 49] . Ruizadhesion promoting and chemoattractant effects of angiotensin II remains unclear thus far. Ortega et al observed a significant reduction in glomerular and interstitial infiltration in rats with immune comChemoattractants for monocytes/macrophages include MCP-1 and TGF-␤ 1 . Both play a major role in plex nephritis treated with the ACE inhibitor quinalapril [42] . However, how ACE inhibition interferes with the chronic renal allograft rejection [39] and chronic in-flammatory responses, as observed in transplant vasculoFurthermore, we demonstrated that enalapril also reduced the expression of IGF-I mRNA, a chemoattracpathy [39] . Moreover, MCP-1 may also activate or increase the expression of adhesion molecules and thus tant for SMCs with fibrotic activity. Recently, angiotensin II has been shown to exert proapoptotic and facilitate monocyte adhesion. In this experiment, similar to the observations of Nadeau, Azuma, and Tilney [39] , antiapoptotic effects in various cell types, including SMCs [55] . In addition, ACE inhibitors have been rea progressive increase in MCP-1 mRNA levels was detected in kidney allografts, preceding macrophage infilported to enhance apoptosis that occurred in association with regression of vascular growth, as a part of their tration. In the present study, long-term enalapril treatment significantly decreased the expression of MCP-1 antihypertensive and/or antihypertrophic effect [58] . Apart from a reduced angiotensin II formation, ACE and TGF-␤ 1 levels. TGF-␤-like immunoreactivity was mainly localized to interstitial cells within the graft.
inhibition also increases bradykinin concentrations, with the subsequent generation of nitric oxide and prostaglanThese results were paralleled by a significantly reduced expression of ICAM-1 and VCAM-1 in the enalapril dins. Thus, the beneficial effects of ACE inhibitors may not be mediated only within the kidney. group as compared with controls. These results could also be explained by the modification of angiotensin II In summary, we demonstrated that the administration of the ACE inhibitor enalapril attenuates the developeffects on adhesion, migration, and proliferation of mononuclear cells [42, 50] . ment of severe proteinuria, ameliorates morphological lesions, and decreases leukocyte infiltration and the Theoretically, many effects of ACE inhibitors in vivo can be attributed to an inhibition of the angiotensin II mRNA levels of growth factors and cytokines in the process of chronic rejection. In the future, this class of production [51] [52] [53] . In our experiment, angiotensinogen was up-regulated when compared with controls. This drugs could prove efficient in clinical practice to reduce the pace of chronic renal allograft rejection, thus increasobservation supports the report of Jonsson, Frewin, and Head, who also demonstrated an up-regulation of angioing long-term renal allograft survival. tensinogen following continuous administration of an ACE inhibitor [54] . Therefore, we can assume that the ACKNOWLEDGMENTS conversion from angiotensin I to angiotensin II was has been reported to elevate mRNA encoding PDGF-A E-mail: uwe.heemann@uni-essen.de chain and TGF-␤ 1 in cultured vascular SMCs [55] . Angiotensin II blockade prevented all of these changes, and REFERENCES coincubation with TGF-␤ 1 -neutralizing antibodies prevented extracellular matrix synthesis. Angiotensin II in-1. Schweitzer EJ, Matas AJ, Gillingham KJ: Causes of renal allograft loss: Progress in the 1980s, challenges for the 1990s. Ann creased the conversion of latent to active TGF-␤ 1 [46] Surg 214: [679] [680] [681] [682] [683] [684] [685] [686] [687] [688] 1991 and increased TGF-␤ 1 mRNA levels in glomeruli [46] . The reduction of mRNA levels of growth factors in 652, 1983 chronically rejecting kidney induced by enalapril treat-9. Hostetter TH, Olson JL, Rennke HG, Venkatachalan MA, Brenner BM: Hyperfiltration in remnant nephrons: A potentially ment in our experiment is consistent with this hypothesis.
